|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005953,
umls-concept:C0030705,
umls-concept:C0034380,
umls-concept:C0183683,
umls-concept:C0344211,
umls-concept:C0439231,
umls-concept:C0439859,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1521721
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-8-26
|
|
pubmed:abstractText |
Over the past decade, high dose chemotherapy with autologous bone marrow (HDC-ABMT) support has been used increasingly in the treatment of patients with breast cancer. In evaluating the results of HDC-ABMT in patients with breast cancer, an assessment of quality of life can add to the traditional endpoints (toxicity, and disease-free and overall survival) that are routinely assessed in clinical trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1057-9249
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
167-76
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10335560-Adult,
pubmed-meshheading:10335560-Bone Marrow Transplantation,
pubmed-meshheading:10335560-Breast Neoplasms,
pubmed-meshheading:10335560-Combined Modality Therapy,
pubmed-meshheading:10335560-Depressive Disorder,
pubmed-meshheading:10335560-Dose-Response Relationship, Drug,
pubmed-meshheading:10335560-Drug Therapy,
pubmed-meshheading:10335560-Female,
pubmed-meshheading:10335560-Humans,
pubmed-meshheading:10335560-Middle Aged,
pubmed-meshheading:10335560-Quality of Life,
pubmed-meshheading:10335560-Questionnaires,
pubmed-meshheading:10335560-Sexual Behavior,
pubmed-meshheading:10335560-Survival,
pubmed-meshheading:10335560-Time Factors,
pubmed-meshheading:10335560-Transplantation, Autologous
|
|
pubmed:articleTitle |
Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
|
|
pubmed:affiliation |
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
